Nicholas Solter

Title: **Nicholas Solter: Innovator in Immunoassay Technology**

Introduction

Nicholas Solter, located in Louisville, Colorado, is an accomplished inventor known for his contributions to the field of immunoassay technology. His innovative approach combines digital solutions with traditional testing methods, offering advancements in medical diagnostics.

Latest Patents

Nicholas holds a patent for a groundbreaking system and method for digital remote primary, secondary, and tertiary color calibration via smart devices in the analysis of medical test results. The patent describes a method for providing immunoassay test results that includes several critical steps. These include collecting biological samples with a testing device, conjugating them with particles, and creating an immune complex. The process further involves binding the immune complex to specific test lines and utilizing a mobile application to capture images for analysis. By comparing color values within the images captured, the system determines test outcomes, presenting results clearly on the user's device screen.

Career Highlights

Nicholas Solter is associated with Reliant Immune Diagnostics, Inc., a company focused on innovative diagnostic solutions. His work has significantly influenced how immunoassay tests are interpreted and communicated, enhancing the efficiency and accuracy of medical testing.

Collaborations

Throughout his career, Nicholas has partnered with notable professionals in the field, including Jovan Hutton Pulitzer and Henry Joseph Legere, III. These collaborations have fostered a rich environment for innovation and development, driving advancements in health technology and diagnostic methodologies.

Conclusion

Nicholas Solter exemplifies the spirit of innovation in modern medicine through his inventive contributions. His patented methods for analyzing immunoassay tests not only showcase his ingenuity but also underscore the potential for technology to improve healthcare outcomes. His ongoing work with Reliant Immune Diagnostics, Inc. and collaborations with esteemed colleagues continue to pave the way for future inventions in medical diagnostics.